|
nasdaq:cdxs
|
21842
|
Apr 21st, 2024 12:00AM
|
Codexis, Inc.
|
17K
|
242.00
|
Open
|
|
Apr 20th, 2024 11:09PM
|
Apr 20th, 2024 11:09PM
|
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
|
Open
|
Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, Genomics, RNA manufacturing, RNA detection, and Oligo synthesis
|
Open
|
200 Penobscot Drive
|
Redwood City
|
CA
|
US
|
94063
|
|
Codexis
|
Basic Materials
|
Chemicals
|
|
nasdaq:cdxs
|
21842
|
Apr 20th, 2024 12:00AM
|
Codexis, Inc.
|
17K
|
242.00
|
Open
|
|
Apr 19th, 2024 11:08PM
|
Apr 20th, 2024 04:44PM
|
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
|
Open
|
Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, Genomics, RNA manufacturing, RNA detection, and Oligo synthesis
|
Open
|
200 Penobscot Drive
|
Redwood City
|
CA
|
US
|
94063
|
|
Codexis
|
Basic Materials
|
Chemicals
|
|
nasdaq:cdxs
|
21842
|
Apr 19th, 2024 12:00AM
|
Codexis, Inc.
|
17K
|
244.00
|
Open
|
|
Apr 18th, 2024 11:15PM
|
Apr 18th, 2024 11:15PM
|
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
|
Open
|
Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, Genomics, RNA manufacturing, RNA detection, and Oligo synthesis
|
Open
|
200 Penobscot Drive
|
Redwood City
|
CA
|
US
|
94063
|
|
Codexis
|
Basic Materials
|
Chemicals
|
|
nasdaq:cdxs
|
21842
|
Apr 18th, 2024 12:00AM
|
Codexis, Inc.
|
17K
|
244.00
|
Open
|
|
Apr 17th, 2024 11:14PM
|
Apr 18th, 2024 06:04PM
|
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
|
Open
|
Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, Genomics, RNA manufacturing, RNA detection, and Oligo synthesis
|
Open
|
200 Penobscot Drive
|
Redwood City
|
CA
|
US
|
94063
|
|
Codexis
|
Basic Materials
|
Chemicals
|
|
nasdaq:cdxs
|
21842
|
Apr 17th, 2024 12:00AM
|
Codexis, Inc.
|
17K
|
245.00
|
Open
|
|
Apr 16th, 2024 11:05PM
|
Apr 17th, 2024 02:28PM
|
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
|
Open
|
Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, Genomics, RNA manufacturing, RNA detection, and Oligo synthesis
|
Open
|
200 Penobscot Drive
|
Redwood City
|
CA
|
US
|
94063
|
|
Codexis
|
Basic Materials
|
Chemicals
|
|
nasdaq:cdxs
|
21842
|
Apr 16th, 2024 12:00AM
|
Codexis, Inc.
|
17K
|
245.00
|
Open
|
|
Apr 15th, 2024 10:58PM
|
Apr 16th, 2024 10:44AM
|
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
|
Open
|
Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, Genomics, RNA manufacturing, RNA detection, and Oligo synthesis
|
Open
|
200 Penobscot Drive
|
Redwood City
|
CA
|
US
|
94063
|
|
Codexis
|
Basic Materials
|
Chemicals
|
|
nasdaq:cdxs
|
21842
|
Apr 15th, 2024 12:00AM
|
Codexis, Inc.
|
17K
|
245.00
|
Open
|
|
Apr 14th, 2024 10:57PM
|
Apr 15th, 2024 04:25PM
|
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
|
Open
|
Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, Genomics, RNA manufacturing, RNA detection, and Oligo synthesis
|
Open
|
200 Penobscot Drive
|
Redwood City
|
CA
|
US
|
94063
|
|
Codexis
|
Basic Materials
|
Chemicals
|
|
nasdaq:cdxs
|
21842
|
Apr 14th, 2024 12:00AM
|
Codexis, Inc.
|
17K
|
246.00
|
Open
|
|
Apr 13th, 2024 10:46PM
|
Apr 14th, 2024 10:44AM
|
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
|
Open
|
Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, Genomics, RNA manufacturing, RNA detection, and Oligo synthesis
|
Open
|
200 Penobscot Drive
|
Redwood City
|
CA
|
US
|
94063
|
|
Codexis
|
Basic Materials
|
Chemicals
|
|
nasdaq:cdxs
|
21842
|
Apr 13th, 2024 12:00AM
|
Codexis, Inc.
|
17K
|
246.00
|
Open
|
|
Apr 12th, 2024 10:37PM
|
Apr 13th, 2024 11:12AM
|
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
|
Open
|
Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, Genomics, RNA manufacturing, RNA detection, and Oligo synthesis
|
Open
|
200 Penobscot Drive
|
Redwood City
|
CA
|
US
|
94063
|
|
Codexis
|
Basic Materials
|
Chemicals
|
|
nasdaq:cdxs
|
21842
|
Apr 12th, 2024 12:00AM
|
Codexis, Inc.
|
17K
|
246.00
|
Open
|
|
Apr 11th, 2024 10:41PM
|
Apr 12th, 2024 08:07AM
|
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
|
Open
|
Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, Life Sciences, Enzyme replacement therapy, API manufacturing, Pharmaceutical manufacturing, Genomics, RNA manufacturing, RNA detection, and Oligo synthesis
|
Open
|
200 Penobscot Drive
|
Redwood City
|
CA
|
US
|
94063
|
|
Codexis
|
Basic Materials
|
Chemicals
|